Europe & Central Asia vs Myanmar: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and

Europe & Central Asia
15.7%
in 2021
Myanmar
24.0%
in 2021
Europe & Central Asia rank
38th
Myanmar rank
38th

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time

  • Europe & Central Asia
  • Myanmar
0102030200020102021

How they compare

Myanmar currently reports 24.0% against 15.7% in Europe & Central Asia, a difference of 8.3%.

That makes Myanmar's figure about 1.5 times Europe & Central Asia's.

Across all 22 years both countries report, Myanmar has been ahead every year.

Europe & Central Asia ranks 38th and Myanmar ranks 38th of 47 groups.

Myanmar has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Europe & Central Asia Myanmar Difference Ahead
2000s 22.0% 31.8% 9.8% Myanmar
2010s 17.7% 26.4% 8.7% Myanmar
2020s 15.8% 24.9% 9.1% Myanmar

Averages of every year both report within each decade.

Frequently asked questions

Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Europe & Central Asia or Myanmar?
Myanmar, at 24.0% against 15.7% in Europe & Central Asia as of 2021.
What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Europe & Central Asia and Myanmar?
8.3%, with Myanmar ahead.
How many years of comparable data are there for Europe & Central Asia and Myanmar?
22 years are reported by both, from 2000 to 2021.
How do Europe & Central Asia and Myanmar rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Europe & Central Asia ranks 38th and Myanmar ranks 38th of 47 groups.
Where does this data come from?
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia vs Myanmar: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 16 September 2026, from https://health.statizoid.com/compare/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-percent/europe-and-central-asia/myanmar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-percent/europe-and-central-asia/myanmar/">Europe & Central Asia vs Myanmar: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).